Posts Tagged "avandia"

FDA panel: "Diabetes Drug Should Stay on Market"

Posted on Aug 9, 2010 in Uncategorized

GaxoSmithKline’s drug Avandia should stay on the market, federal health experts voted Wednesday, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects. A panel of Food and Drug Administration advisers voted 20-12 to keep the once blockbuster pill available for diabetics. But 10 panelists also called for limiting who can receive and prescribe the much-debated medication. The vote marks a tough win for British drugmaker Glaxo, which is facing thousands of lawsuits from patients who say Avandia caused their heart attacks or strokes....

Read More

90 Percent of Scientists Backing Avandia Diabetes Drug Had Financial Ties to Drug Companies

Posted on Jul 28, 2010 in Uncategorized

Friday, July 23, 2010 by: David Gutierrez More than 90 percent of researchers who have published studies favorable to the controversial diabetes drug Avandia had a financial stake in the issue, according to a study conducted by researchers from the Mayo Clinic. The Mayo Clinic is one of the few research organizations in the United States that does not accept corporate funding. Sales of GlaxoSmithKline’s bestselling drug Avandia plunged in 2007, after evidence emerged linking the drug to an increased risk of heart attack and death. These reports sparked a debate over the drug’s...

Read More

Controversial Avandia Study Faces FDA Scrutiny

Posted on Apr 20, 2010 in Uncategorized

Date Published: Monday, April 19th, 2010   A large Avandia study could be terminated by the U.S. Food & Drug Administration (FDA) over ethical concerns. The FDA’s decision on whether to continue the trial, known as TIDE, could ultimately impact whether the controversial diabetes drug is allowed to remain on the market. Avandia has been the subject of safety concerns for several years. In November 2007, a black box warning – the FDA’s strongest safety warning – detailing Avandia’s association with myocardial ischemia was added to the drug’s labeling. The black box was added after the...

Read More